PROMED-COG: PROtein enriched MEDiterranean diet to combat undernutrition and promote healthy neuroCOGnitive ageing in older adults

Study Code / Acronym
PROMED-COG
Award Number
BB/V019201/1
Status / Stage
Active
Dates
1 March 2021 -
31 August 2023
Duration (calculated)
02 years 05 months
Funder(s)
BBSRC (UKRI)
Funding Amount
£263,746.00
Funder/Grant study page
BBSRC UKRI
Contracted Centre
Queen's University of Belfast
Contracted Centre Webpage
Principal Investigator
Dr Claire McEvoy
PI Contact
c.mcevoy@qub.ac.uk
PI ORCID
0000-0001-8512-3293
WHO Catergories
Methodologies and approaches for risk reduction research
Risk reduction intervention
Understanding Underlying Disease
Disease Type
Dementia (Unspecified)

CPEC Review Info
Reference ID373
ResearcherReside Team
Published12/06/2023

Data

Study Code / AcronymPROMED-COG
Award NumberBB/V019201/1
Status / StageActive
Start Date20210301
End Date20230831
Duration (calculated) 02 years 05 months
Funder/Grant study pageBBSRC UKRI
Contracted CentreQueen's University of Belfast
Contracted Centre Webpage
Funding Amount£263,746.00

Abstract

Dementia is a major public health challenge owing to its increasing prevalence and impact on disability and quality of life among older adults. Undernutrition, defined as a ‘state resulting from inadequate food intake and/or nutrient deficiencies that leads to an altered body composition and weight loss’, is common in cognitive impairment and has many adverse consequences. Undernourished dementia patients experience faster functional and cognitive decline, more psychiatric symptoms, and greater risk of hospitalisation and death, compared to those who are adequately nourished. Importantly, weight loss increases dementia risk by 30-40% and precedes a diagnosis of cognitive impairment or dementia by at least one decade, providing a window of opportunity to intervene with strategies to counteract undernutrition and delay, or prevent, the onset of dementia in later life. No prior studies have evaluated the effect of diet and exercise on cognitive performance. The PROMED-EX trial is a single blind randomised controlled trial in 105 undernourished adults with subjective cognitive decline to: (i) test the effects of a protein optimised Mediterranean diet, with and without exercise, on nutritional status and cognitive performance; (ii) generate data on the mechanistic pathways by which the diet and exercise intervention may act to influence nutritional status and cognition, and (iii) understand the acceptability of diet and exercise to support better nutrition status and cognitive performance. PROMED-EX is part of a European Consortium project (PROMED-COG) to better understand the role of undernutrition in dementia risk and and how modifications of diet and exercise behaviour can act to reduce the burden of undernutrition and neurodegeneration. The resulting scientific knowledge will be translated into public and practice recommendations to prevent undernutrition for healthy neurocognitive ageing in older European citizens.

Aims

The aims of the PROMED-EX trial are to: (i) determine the effect of a protein enriched Mediterranean diet, with and without exercise, on cognitive function; (ii) understand how a protein enriched Mediterranean diet and exercise may act to influence nutritional status, and; (iii) evaluate the acceptability of diet and exercise to support better nutrition status and cognitive performance in older adults with subjective memory complaint. PROMED-EX is part of a larger European project to study how undernutrition can affect dementia risk in later life.